Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

More specimen sharing would yield more breakthroughs

Researchers are having a hard time getting their hands on specimens for their work on new treatments, diagnostics, and cures.

Read More »

Pfizer Terminates PDC Agreement with CytomX Therapeutics

Pfizer Inc. notified CytomX Therapeutics Inc. of its intent to terminate a five-year-old oncology collaboration with the Bay Area-based company.

Read More »

FDA approves new indication for Gilotrif

The U.S. FDA approved a supplemental NDA for Gilotrif (afatinib) for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have non-resistant epidermal growth factor receptor mutations as detected by an FDA-approved test.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom